Some studies show that atomoxetine (Strattera) produces measurable improvement in CDS symptoms that can be statistically separated from improvement in ADHD symptoms, supporting CDS as a distinct treatable condition.
causalpending
Speaker
Dr. John CruiseEvidence Quote
“there are a few studies looking at atomoxetine Strattera with um improvement in both again cognitive disengagement symptoms, which can be statistically separated out from just the improvement in ADHD symptoms”
Created: 8/10/2026, 10:49:40 PM
Your notes
Loading notes...